Hibiscus Sabdariffa Linnaeus Aqueous Extracts Attenuate the Progression of Renal Injury in 5/6 Nephrectomy Rats

REFERENCES

• National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266.
   PubMed Web of Science ®Google Scholar
• Patel SS, Kimmel PL, Singh A. New clinical practice guidelines for chronic kidney disease: a framework for K/DOQI. Semin Nephrol. 2002;22:449–458.
   PubMed Web of Science ®Google Scholar
• Mitka M. Report notes increase in kidney disease. JAMA. 2008;300:2473–2474.
   PubMed Web of Science ®Google Scholar
• Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12.
   PubMed Web of Science ®Google Scholar
• Herrera-Arellano A, Flores-Romero S, Chavez-Soto MA, Tortoriello J. Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial. Phytomedicine. 2004;11:375–382.
   PubMed Web of Science ®Google Scholar
• Wang CJ, Wang JM, Lin WL, Chu CY, Chou FP, Tseng TH. Protective effect of Hibiscus anthocyanins against tert-butyl hydroperoxide-induced hepatic toxicity in rats. Food Chem Toxicol. 2000;38:411–416.
   PubMed Web of Science ®Google Scholar
• Gowali FM. Hibiscin for mucin. Stain Technol. 1982;57:57–58.
   PubMed Web of Science ®Google Scholar
• Hirunpanich V, Utaipat A, Morales NP, . Hypocholesterolemic and antioxidant effects of aqueous extracts from the dried calyx of Hibiscus sabdariffa L. in hypercholesterolemic rats. J Ethnopharmacol. 2006;103:252–260.
   PubMed Web of Science ®Google Scholar
• Hirunpanich V, Utaipat A, Morales NP, . Antioxidant effects of aqueous extracts from dried calyx of Hibiscus sabdariffa Linn. (Roselle) in vitro using rat low-density lipoprotein (LDL). Biol Pharm Bull. 2005;28:481–484.
   PubMed Web of Science ®Google Scholar
• Mojiminiyi FB, Dikko M, Muhammad BY, . Antihypertensive effect of an aqueous extract of the calyx of Hibiscus sabdariffa. Fitoterapia. 2007;78:292–297.
   PubMed Web of Science ®Google Scholar
• Odigie IP, Ettarh RR, Adigun SA. Chronic administration of aqueous extract of Hibiscus sabdariffa attenuates hypertension and reverses cardiac hypertrophy in 2K-1C hypertensive rats. J Ethnopharmacol. 2003;86:181–185.
   PubMed Web of Science ®Google Scholar
• Adegunloye BJ, Omoniyi JO, Owolabi OA, Ajagbonna OP, Sofola OA, Coker HA. Mechanisms of the blood pressure lowering effect of the calyx extract of Hibiscus sabdariffa in rats. Afr J Med Med Sci. 1996;25:235–238.
   PubMedGoogle Scholar
• Sarr M, Ngom S, Kane MO, . In vitro vasorelaxation mechanisms of bioactive compounds extracted from Hibiscus sabdariffa on rat thoracic aorta. Nutr Metab (Lond). 2009;6:45.
   PubMed Web of Science ®Google Scholar
• Jonadet M, Bastide J, Bastide P, Boyer B, Carnat AP, Lamaison JL. [In vitro enzyme inhibitory and in vivo cardioprotective activities of hibiscus (Hibiscus sabdariffa L.)]. J Pharm Belg. 1990;45:120–124.
   PubMed Web of Science ®Google Scholar
• Lee WC, Wang CJ, Chen YH, . Polyphenol extracts from Hibiscus sabdariffa Linnaeus attenuate nephropathy in experimental type 1 diabetes. J Agric Food Chem. 2009;57: 2206–2210.
   PubMed Web of Science ®Google Scholar
• Griffin KA, Picken M, Bidani AK. Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J Am Soc Nephrol. 1994;4:2023–2031.
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–358.
   PubMed Web of Science ®Google Scholar
• Leelahavanichkul A, Yan Q, Hu X, . Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney Int. 2010;78:1136–1153.
   PubMed Web of Science ®Google Scholar
• MacKay K, Striker LJ, Pinkert CA, Brinster RL, Striker GE. Glomerulosclerosis and renal cysts in mice transgenic for the early region of SV40. Kidney Int. 1987;32:827–837.
   PubMed Web of Science ®Google Scholar
• Farmer EE, Davoine C. Reactive electrophile species. Curr Opin Plant Biol. 2007;10:380–386.
   PubMed Web of Science ®Google Scholar
• Inagi R, Miyata T. Oxidative protein damage with carbohydrates and lipids in uremia: ‘carbonyl stress’. Blood Purif. 1999;17:95–98.
   PubMed Web of Science ®Google Scholar
• Siems W, Quast S, Carluccio F, . Oxidative stress in chronic renal failure as a cardiovascular risk factor. Clin Nephrol. 2002;58(Suppl 1):S12–S19.
   Web of Science ®Google Scholar
• Kadowaki D, Anraku M, Tasaki Y, . Evaluation for antioxidant and renoprotective activity of olmesartan using nephrectomy rats. Biol Pharm Bull. 2009;32:2041–2045.
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Oveisi F, Ding Y. Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int. 1998;53:1748–1754.
   PubMed Web of Science ®Google Scholar
• Paul JL, Man NK, Moatti N, Raichvarg D. [Membrane phospholipid peroxidation in renal insufficiency and chronic hemodialysis]. Nephrologie. 1991;12:4–7.
   PubMedGoogle Scholar
• Trznadel K, Pawlicki L, Kedziora J, Luciak M, Blaszczyk J, Buczynski A. Superoxide anion generation, erythrocytes superoxide dismutase activity, and lipid peroxidation during hemoperfusion and hemodialysis in chronic uremic patients. Free Radic Biol Med. 1989;6:393–397.
   PubMed Web of Science ®Google Scholar
• Durak I, Akyol O, Basesme E, Canbolat O, Kavutcu M. Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure. Nephron. 1994;66:76–80.
   PubMed Web of Science ®Google Scholar
• Turi S, Nemeth I, Vargha I, Matkovics B, Dobos E. Erythrocyte defense mechanisms against free oxygen radicals in hemodialyzed uremic children. Pediatr Nephrol. 1991;5:179–183.
   PubMed Web of Science ®Google Scholar
• Seca AM, Silva AM, Silvestre AJ, Cavaleiro JA, Domingues FM, Pascoal-Neto C. Phenolic constituents from the core of kenaf (Hibiscus cannabinus). Phytochemistry. 2001;56:759–767.
   PubMed Web of Science ®Google Scholar
• Shirwaikar A, Malini S, Kumari SC. Protective effect of Pongamia pinnata flowers against cisplatin and gentamicin induced nephrotoxicity in rats. Indian J Exp Biol. 2003;41:58–62.
   PubMedGoogle Scholar
• Fleet M, Osman F, Komaragiri R, Fritz A. Protein catabolism in advanced renal disease: role of cytokines. Clin Nephrol. 2008;70:91–100.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Heimburger O, Paultre F, . Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55:1899–1911.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Ketteler M, Johnson RJ, . IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia—the good, the bad, and the ugly. Kidney Int. 2005;67:1216–1233.
   PubMed Web of Science ®Google Scholar
• Zoccali C, Mallamaci F, Tripepi G. Inflammation and atherosclerosis in end-stage renal disease. Blood Purif. 2003; 21:29–36.
   PubMed Web of Science ®Google Scholar